C-reactive protein predicts death in patients with previous premature myocardial infarction—A 10 year follow-up study

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

1972 • 31,801 citations

Atherosclerosis — An Inflammatory Disease

1999 • 21,494 citations

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

2000 • 8,612 citations

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

2000 • 5,760 citations

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

1997 • 5,442 citations

Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

1957 • 3,280 citations

The acute phase response

1994 • 2,927 citations

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1994 • 2,343 citations

HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY

1986 • 1,989 citations

C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men

1999 • 1,952 citations

Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

1995 • 1,807 citations

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

2000 • 1,703 citations

Production of C-reactive protein and risk of coronary events in stable and unstable angina

1997 • 1,515 citations

Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

1999 • 1,488 citations

Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein

1983 • 1,283 citations

Fibrinogen as a Cardiovascular Risk Factor

1993 • 1,015 citations

Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.

2000 • 917 citations

C-Reactive Protein as a Cardiovascular Risk Factor

1999 • 824 citations

Obituary. Rupert Samuel Bruce Pearson.

1974 • 760 citations

C-Reactive Protein and Outcome After Ischemic Stroke

1999 • 321 citations

Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment

1996 • 270 citations

Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range

1998 • 169 citations

Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women The Scottish Heart Health Study

1998 • 159 citations

Insertion/deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and myocardial infarction

1993 • 111 citations

DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration

1989 • 80 citations

Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction.

1987 • 53 citations

Emerging approaches in preventing cardiovascular disease

1999 • 37 citations

Radionuclide assessment of ventricular function and risk stratification after myocardial infarction.

1991 • 24 citations

Does qualitatively altered fibrinogen contribute to the increased heparin precipitable fraction (HPF) in acute myocardial infarction (AMI) ?

1984 • 10 citations

Systolic Time Intervals and Ejection Fraction in Assessing Left Ventricular Performance Following Acute Myocardial Infarction

1984 • 6 citations